Sökning: onr:"swepub:oai:DiVA.org:uu-235337" > Angiotensin II Type...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03512naa a2200373 4500 | |
001 | oai:DiVA.org:uu-235337 | |
003 | SwePub | |
008 | 141030s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2353372 URI |
024 | 7 | a https://doi.org/10.1210/en.2014-11852 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Leblanc, Samuel4 aut |
245 | 1 0 | a Angiotensin II Type 2 Receptor Stimulation Improves Fatty Acid Ovarian Uptake and Hyperandrogenemia in an Obese Rat Model of Polycystic Ovary Syndrome |
264 | 1 | b The Endocrine Society,c 2014 |
338 | a print2 rdacarrier | |
520 | a Polycystic ovary syndrome (PCOS) is mainly defined by hyperandrogenism but is also characterized by insulin resistance (IR). Studies showed that overexposure of nonadipose tissues to nonesterified fatty acids (NEFA) may explain both IR and hyperandrogenism. Recent studies indicate that treatment with an angiotensin II type 2 receptor (AT2R)-selective agonist improves diet-induced IR. We thus hypothesized that PCOS hyperandrogenism is triggered by ovarian NEFA overexposure and is improved after treatment with an AT2R agonist. Experiments were conducted in 12-week-old female JCR:LA-cp/cp rats, which are characterized by visceral obesity, IR, hyperandrogenism, and polycystic ovaries. Control JCR:LA +/? rats have a normal phenotype. Rats were treated for 8 days with saline or the selective AT2R agonist C21/M24 and then assessed for: 1) fasting testosterone, NEFA, and insulin levels; and 2) an iv 14(R,S)-[F-18]fluoro-6-thia-heptadecanoic acid test to determine NEFA ovarian tissue uptake (Km). Compared with controls, saline-treated PCOS/cp rats displayed higher insulin (100 vs 5.6 mu U/mL), testosterone (0.12 vs 0.04 nmol/L), NEFA (0.98 vs 0.48 mmol/L), and Km (20.7 vs 12.9 nmol/g.min) (all P < .0001). In PCOS/cp rats, C21/M24 did not significantly improve insulin or NEFA but normalized testosterone (P = .004) and Km(P = .009), which were strongly correlated together in all PCOS/cp rats (rho = 0.74, P = .009). In conclusion, in an obese PCOS rat model, ovarian NEFA uptake and testosterone levels are strongly associated and are both significantly reduced after short-term C21/M24 therapy. These findings provide new information on the role of NEFA in PCOS hyperandrogenemia and suggest a potential role for AT2R agonists in the treatment of PCOS. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Battista, Marie-Claude4 aut |
700 | 1 | a Noll, Christophe4 aut |
700 | 1 | a Hallberg, Andersu Uppsala universitet,Avdelningen för organisk farmaceutisk kemi4 aut0 (Swepub:uu)andehall |
700 | 1 | a Gallo-Payet, Nicole4 aut |
700 | 1 | a Carpentier, Andre C.4 aut |
700 | 1 | a Vine, Donna F.4 aut |
700 | 1 | a Baillargeon, Jean-Patrice4 aut |
710 | 2 | a Uppsala universitetb Avdelningen för organisk farmaceutisk kemi4 org |
773 | 0 | t Endocrinologyd : The Endocrine Societyg 155:9, s. 3684-3693q 155:9<3684-3693x 0013-7227x 1945-7170 |
856 | 4 | u https://academic.oup.com/endo/article-pdf/155/9/3684/10827768/endo3684.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-235337 |
856 | 4 8 | u https://doi.org/10.1210/en.2014-1185 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.